Omada Health (NASDAQ:OMDA) CFO Steven Cook Sells 1,884 Shares

Omada Health, Inc. (NASDAQ:OMDA) CFO Steven Cook sold 1,884 shares of the company’s stock in a transaction that occurred on Friday, March 13th. The stock was sold at an average price of $13.94, for a total transaction of $26,262.96. Following the sale, the chief financial officer directly owned 200,512 shares in the company, valued at approximately $2,795,137.28. The trade was a 0.93% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Omada Health Stock Performance

Shares of OMDA opened at $14.62 on Wednesday. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $28.40. The stock has a 50-day simple moving average of $13.85 and a 200-day simple moving average of $18.26. The stock has a market capitalization of $861.41 million and a PE ratio of -86.00.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, March 5th. The company reported $0.08 EPS for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.12. The firm had revenue of $75.85 million for the quarter.

Analysts Set New Price Targets

OMDA has been the subject of a number of recent analyst reports. BMO Capital Markets reduced their price objective on shares of Omada Health from $27.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, March 6th. Canaccord Genuity Group reduced their price target on Omada Health from $28.00 to $22.00 and set a “buy” rating for the company in a report on Friday, March 6th. Barclays dropped their price objective on Omada Health from $22.00 to $17.00 and set an “overweight” rating on the stock in a report on Tuesday, March 3rd. The Goldman Sachs Group reiterated a “buy” rating and issued a $26.00 price objective on shares of Omada Health in a research report on Friday, January 16th. Finally, Wall Street Zen raised Omada Health from a “hold” rating to a “buy” rating in a report on Saturday. Eight investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Omada Health presently has a consensus rating of “Moderate Buy” and a consensus price target of $23.60.

Hedge Funds Weigh In On Omada Health

A number of institutional investors have recently made changes to their positions in the stock. Quarry LP acquired a new position in Omada Health in the 4th quarter valued at about $29,000. TD Waterhouse Canada Inc. purchased a new position in Omada Health in the fourth quarter valued at approximately $32,000. Raymond James Financial Inc. acquired a new position in shares of Omada Health during the 2nd quarter valued at $32,000. Strs Ohio acquired a new position in shares of Omada Health during the third quarter worth about $38,000. Finally, Inlight Wealth Management LLC purchased a new position in Omada Health in the 4th quarter worth approximately $45,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.